Related Experiment Video

Updated: Apr 29, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

17.6K

A national study of the processes and outcomes of paediatric formulary applications in Australia

Yashwant K Sinha1, Jonathan C Craig2, Peter G Barclay3

  • 1The Children's Hospital at Westmead, Sydney, NSW, Australia. yashwant.sinha@health.nsw.gov.au.

The Medical Journal of Australia
|May 20, 2014
PubMed

Insights

Australian paediatric hospitals show inconsistent drug approval processes. Limited high-quality evidence supports decisions, leading to duplicated efforts and variable outcomes. A national approach is recommended for better drug evaluation.

Area of Science:

  • Health Services Research
  • Pharmacoeconomics
  • Paediatric Pharmacology

Background:

  • Pharmaceutical formulary inclusion is critical for paediatric patient care.
  • Existing processes for drug approval in Australian paediatric hospitals lack standardization.
  • Variability in evidence requirements impacts drug accessibility and safety.

Purpose of the Study:

  • To evaluate the processes of pharmaceutical formulary addition in Australian paediatric hospitals.
  • To identify variations in drug approval procedures and their outcomes.
  • To assess the quality of evidence supporting drug submissions.

Main Methods:

  • A descriptive study analyzed all submissions to Australian paediatric hospital drug and therapeutics committees (2010-2011).
  • Data collection involved interviews with committee secretaries and document analysis.
  • Key outcomes included application numbers, approval rates, and quality of supporting information.

Main Results:

  • 120 applications were reviewed, with high approval rates (67%-100%). Neurological agents were most frequent.
  • Supporting data often lacked high-level evidence (e.g., systematic reviews, meta-analyses).
  • Significant institutional variation in processes, outcomes, and evidence review was observed.

Conclusions:

  • Paediatric hospital drug approvals are often based on limited high-quality evidence.
  • Inconsistent processes and duplicated efforts necessitate a standardized national approach.
  • Improved resource allocation and training are needed for complex drug evaluations.
Abstract

More Related Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

11.2K
Intratracheal Administration of Dry Powder Formulation in Mice07:55

Intratracheal Administration of Dry Powder Formulation in Mice

Published on: July 25, 2020

11.2K

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
405
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
963
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K